Added to YB: 2026-07-02
Pitch date: 2026-04-26
QDEL [bullish]
QuidelOrtho Corporation
+58.16%
current return
Author Info
No bio for this author
Company Info
QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics business units.
Market Cap
$1.2B
Pitch Price
$11.49
Price Target
N/A
Dividend
N/A
EV/EBITDA
7.31
P/E
-0.98
EV/Sales
1.48
Sector
Health Care Equipment and Supplies
Category
value
QuidelOrtho Corporation - $QDEL
QDEL: Diagnostics turnaround at ~2.5-3x normalized earnings after stock fell 90%+ to $11 (<$1bn mkt cap). Market zeroed China EV & wrote off FCF conversion; Q1 revenue miss deemed cyclical (weak flu, EMEA/China timing). Core labs franchise MSD growth, EBITDA to $800M/26% margin by 2028, ~$4+ EPS, $750M FCF (~100% of mkt cap). Insider buying, NOL shields cash tax, exec comp tied to FCF. Base 12x P/E = 4.6x MOIC; bear ~10% downside. PE/activist optionality (HOLX LBO'd at higher leverage than QDEL's EV/EBITDA). >18mo duration. Risk: FCF never inflects.
Read full article (17 min)